Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karussis, D
Right arrow Articles by Chapman, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karussis, D
Right arrow Articles by Chapman, J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Multiple Sclerosis, Vol. 9, No. 5, 476-480 (2003)
DOI: 10.1191/1352458503ms950oa
© 2003 SAGE Publications

Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis

D Karussis

Department of Neurology, Laboratory of Neuroimmunology and the Agnes Ginges Center for Neurogenetics, Hadassah Medical Center, Hebrew University, Jerusalem, Israel, karus{at}cc.huji.ac.il

D M Michaelson

Department of Neurobiochemistry, Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel

N Grigoriadis

Department of Neurology, Laboratory of Neuroimmunology and the Agnes Ginges Center for Neurogenetics, Hadassah Medical Center, Hebrew University, Jerusalem, Israel

A D Korezyn

Departments of Physiology and Pharmacology, and Neurology, Sieratzki Chair of Neurology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

R Mizrachi-Koll

Department of Neurology, Laboratory of Neuroimmunology and the Agnes Ginges Center for Neurogenetics, Hadassah Medical Center, Hebrew University, Jerusalem, Israel

S Chapman

Department of Neurobiochemistry, Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel

O Abramsky

Department of Neurology, Laboratory of Neuroimmunology and the Agnes Ginges Center for Neurogenetics, Hadassah Medical Center, Hebrew University, Jerusalem, Israel

J Chapman

Departments of Physiology and Pharmacology, and Neurology, Sieratzki Chair of Neurology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Experimental autoimmune encephalomyelitis (EAE) was found to have a chronic and significantly worse course in apolipoprotein-E (apoE) deficient female mice when compared with matched controls. Disease measures compared included incidence of EAE (64% versus 31%, P <0.05, x2 test), maximal clinical score (average ±SD 2.81±2.5 versus 0.75±1.1, P <0.01, Mann -Whitney test) and mortality (27.3% versus 0%, P =0.02, Mann -Whitney test and x2 test). A poE deficient mice had significantly increased lymphocyte proliferation responses to both myelin antigens and mitogens and significantly more infiltrating lesions in the central nervous system (CNS) in histopatho logy. Defective neuronal repair mechanisms and enhanced immune reactivity in apoE deficient mice may explain our findings. C linical implications for MS are discussed.

Key Words: A lzheimer’s disease • apoE • experimental autoimmune encephalomyelitis (EA E) • multiple sclerosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
F.-Q. Li, G. D. Sempowski, S. E. McKenna, D. T. Laskowitz, C. A. Colton, and M. P. Vitek
Apolipoprotein E-Derived Peptides Ameliorate Clinical Disability and Inflammatory Infiltrates into the Spinal Cord in a Murine Model of Multiple Sclerosis
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 956 - 965.
[Abstract] [Full Text] [PDF]